功能性便秘患儿的肠道菌群分析及治疗干预

刘四香; 黄永坤; 王明英; 胡红卫; 马敏; 凌昱

doi:10.12259/j.issn.2095-610X.S20220309

功能性便秘患儿的肠道菌群分析及治疗干预

doi: 10.12259/j.issn.2095-610X.S20220309

1.
昆明医科大学附属儿童医院儿保科，云南昆明　650034
2.
昆明医科大学第一附属医院儿科，云南昆明　650032
3.
昆明医科大学附属儿童医院消化内科，云南昆明　650034

基金项目: 昆明市科技计划项目（2019-1-S-25318000001121）

详细信息

作者简介:
刘四香（1987～），女，云南南涧人，医学硕士，主治医师，主要从事儿童保健与消化系统疾病诊治的临床工作

通讯作者:
凌昱， E-mail：lingyu@etyy.cn

中图分类号: R72
计量
- 文章访问数: 4037
- HTML全文浏览量: 2416
- PDF下载量: 23
- 被引次数: 0
出版历程
- 收稿日期: 2022-01-19
- 网络出版日期: 2022-02-18
- 刊出日期: 2022-03-22

Analysis of Intestinal Flora and Therapeutic Intervention in Children with Functional Constipation

1.
Dept. of Children Healthcare，The Affiliated Children Hospital of Kunming Medical University，Kunming Yunnan 650034
2.
Dept. of Pediatrics，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032
3.
Dept. of Gastroenterology，The Affiliated Children Hospital of Kunming Medical University，Kunming Yunnan 650034，China

摘要

摘要: 目的分析功能性便秘（FC）患儿肠道菌群含量的变化及非药物基础治疗的临床疗效。方法选取2019年9月至2021年10月在昆明医科大学附属儿童医院消化内科门诊诊断为FC的患儿30例作为研究对象，选取同期来该院儿童保健科体检的30例健康儿童作为正常对照组。收集FC患儿经饮食结构调整、定时排便训练、适量运动等基础治疗前、治疗后和正常对照组的粪便标本。利用昆明合和医学检验所的MiNi8 plus荧光定量PCR仪测定各组儿童粪便中的肠道菌群含量。同时观察FC患儿经基础治疗后便秘症状的缓解情况。结果 FC患儿双歧杆菌属、乳酸杆菌属含量显著低于正常对照组，差异有统计学意义（P < 0.01）。FC患儿经基础治疗后乳酸杆菌属含量较治疗前组明显增多，差异有统计学意义（P < 0.01）。FC患儿经基础治疗后便秘症状评分均较治疗前组降低，差异有统计学意义（P < 0.01）。结论 FC患儿会出现肠道菌群紊乱，经饮食结构调整、生活方式改善等基础治疗后肠道菌群紊乱和便秘症状得以改善。
- 功能性便秘 /
- 肠道菌群 /
- 基础治疗 /
- 儿童
Abstract: Objective To analyze the changes of intestinal flora in children with functional constipation （FC） and the clinical significance of non-pharmacological basic treatment. Methods A total of 30 children with FC were selected from the outpatient department of the Children's Hospital affiliated to Kunming Medical University between September 2019-October 2021, and 30 health children were selected as control group. The children with FC were given basic treatment that including dietary structure adjustment, regular defecation training and appropriate exercise.The fecal samples were collected respectively in the pre-treatment group and post-treatment group from the children with FC and from the healthy children. The contents of intestinal flora in the stools of children in each group were measured by the MiNi8 plus fluorescence quantitative PCR instrument from the Kunming Hehe Medical Laboratory. In addition, the relief of constipation symptoms after basic treatment in children with FC was observed. Results The content of lactobacillus and bifidobacterium in children with FC was significantly lower than that in control group , and the difference was statistically significant （P < 0.01）. The content of lactobacillus in the post-treatment group was significantly higher than that in the pre-treatment group, and the difference was statistically significant （P < 0.01）. The scores of constipation symptoms in children with FC after basic treatment were lower than those in pre-treatment group, and the difference was statistically significant （P < 0.01）. Conclusions The children with FC will have intestinal flora disorder. After basic treatment such as dietary structure adjustment and lifestyle improvement, the intestinal flora disorder and constipation symptoms can be improved.
- Functional constipation /
- Intestinal flora /
- Basic treatment /
- Children

HTML全文

表 1 便秘组（治疗前组）与正常对照组肠道菌群含量的比较（$\bar x \pm s $）

Table 1. Comparison of intestinal flora between FC and control group （$\bar x \pm s $）

组别	双歧杆菌属	乳酸杆菌属	拟杆菌属	柔嫩梭菌属	埃希氏菌属
便秘组	10.51 ± 0.58	9.00 ± 0.17	11.94 ± 0.82	11.72 ± 0.88	10.62 ± 1.31
对照组	11.39 ± 0.40	10.73 ± 0.75	12.05 ± 0.36	11.48 ± 1.16	10.78 ± 0.61
t	6.874	12.238	0.649	0.911	0.643
P	< 0.001^*	< 0.001^*	0.520	0.366	0.524
^*P < 0.05。

下载: 导出CSV

表 2 治疗前组与治疗后组肠道菌群含量的比较（$\bar x \pm s $）

Table 2. Comparison of intestinal flora between pre-treatment group and post-treatment group （$\bar x \pm s $）

组别	双歧杆菌属	乳酸杆菌属
治疗前组	10.51 ± 0.58	9.00 ± 0.17
治疗后组	10.58 ± 0.55	10.40 ± 0.46
t	1.279	17.312
P	0.211	< 0.001^*
^*P < 0.05。

下载: 导出CSV

表 3 治疗前组与治疗后组的便秘症状评分比较[n/（$\bar x \pm s $）]

Table 3. Comparison of constipation symptom scores between pre-treatment group and post-treatment group [n/（$\bar x \pm s $）]

项目	时间	1分	2分	3分	4分	5分	6分	总分（分）	平均值（分）	t	P
排便次数	治疗前	0	0	0	9	16	5	146	4.87 ± 0.68
	治疗后	6	9	7	5	2	1	81	2.70 ± 1.34	14.231	< 0.001^*
排便困难	治疗前	0	4	23	3	—	—	89	2.97 ± 0.49
	治疗后	17	6	5	2	—	—	52	1.73 ± 0.98	8.729	< 0.001^*
粪便性状	治疗前	1	29	—	—	—	—	59	1.97 ± 0.18
	治疗后	23	7	—	—	—	—	37	1.23 ± 0.43	8.930	< 0.001^*
^*P < 0.05。

下载: 导出CSV

参考文献(21)

[1]	耿岚岚,刘明南,龙高,等. 儿童功能性胃肠病罗马Ⅳ标准[J]. 中华儿科杂志,2017,55(1):4-14. doi: 10.3760/cma.j.issn.0578-1310.2017.01.002
[2]	Koppen I J N,Vriesman M H,Saps M,et al. Prevalence of functional defecation disorders in children:A systematic review and meta-analysis[J]. J Pediatr,2018,198(1):121-130.
[3]	Loening-thucke V,Prevalence. Symptoms and outcome of consti-pation in infants and toddler[J]. J Pediatr,2005,146(3):359-363. doi: 10.1016/j.jpeds.2004.10.046
[4]	Rasquin-Weber A,Hyman P E,Cucehiara S,et al. Childhood funetional gastrointestinal disorders[J]. Gut,1999,45(suppl II):f1160-f1168.
[5]	张良娟,王宝西. 儿童功能性便秘相关检查的研究进展[J]. 临床儿科杂志,2014,32(6):587-590.
[6]	Gastillejo G,Bulló M,Anguera A,et al. A controlled,randomized,double‐blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients[J]. Pediatrics,2006,118(3):641‐648.
[7]	Bleijenberg G,Kuijpers H C. Biofeedback treatment of constlpation:A comparison of two methods[J]. Am J Gastroenterol,1994,89(7):1021-1026.
[8]	Xiong L,Gong X,Siah K T,et al. Rome foundation Asian working team report:real world treatment experience of Asian patients with functional bowel disorders[J]. J Gastroenterol Hepatol,2017,32(8):1450-1456. doi: 10.1111/jgh.13730
[9]	Ranasinghe N,Devanarayana N M,Benninga M A,et al. Psychological maladjustment and quality of life in adolescents with constipation[J]. Arch Dis Child,2017,102(3):268-273.
[10]	Di Lorenzo C,Flores A F,Reddy S N,et al. Use of colonic manometry to differentiate causes of intractable constipation in children[J]. J Pediatr,1992,120(5):690‐695.
[11]	刘海宁,陈玉琢,吴昊,等. 肠道菌群与功能性便秘的研究进展[J]. 复旦学报(医学版),2015,42(4):564-568. doi: 10.3969/j.issn.1672-8467.2015.04.024
[12]	毕洪玲,张桂兰,何嫱. 便秘患者肠菌群的调查[J]. 临床军医杂志,2003,31(3):82-84. doi: 10.3969/j.issn.1671-3826.2003.03.035
[13]	de Moraes J G,Motta M E,Beltrao M F,et al. Fecal microbiota and diet of children with chronic constipationn[J]. Int J Pediatr,2016,2016:6787269.
[14]	Gerritsen J,Smidt H,Rijkers G T. Intestinal microbiota in human health and disease:the impact of probiotics[J]. Genes Nutr,2011,6(3):209-240. doi: 10.1007/s12263-011-0229-7
[15]	Zoppi G,Cinquetti M,Luciano A,et a1. The intestinal ecosystem in chronic functional constipation[J]. Acta paediatrica,1998,87(8):836-841. doi: 10.1111/j.1651-2227.1998.tb01547.x
[16]	de Meij T G,de Groot E F,Eck A,et a1. Characterization of microbiota in children with chronic functional constipation[J]. PloS One,2016,11(10):e0164731. doi: 10.1371/journal.pone.0164731
[17]	朱俊晨,李世敏,魏小青. 双歧杆菌对人体的生理作用及研究进展[J]. 中国微生态学杂志,2002,12(1):53-55.
[18]	Desbonnet L,Garrett L,Clarke G,et a1. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression[J]. Neuroscience,2010,170(4):1179-1188. doi: 10.1016/j.neuroscience.2010.08.005
[19]	Roma E,Adamidis D,Nikolara,et a1. Diet and chronic constipation in children:the role of fiber[J]. J Pediatr Gastroenterol Nutr,1999,28(1):169-174.
[20]	Suares N C,Ford A C. Systematic review:the effects of fibre in the management of chronic idiopathic constipation[J]. Aliment pharmacol Ther,2011,33(8):895-901. doi: 10.1111/j.1365-2036.2011.04602.x
[21]	Guerra P V,Lima L N,Souza T C,et al. Pediatric functional constipation treatment with Bifidobacterium-containing yogurt:a crossover,double-blind,controlled trial[J]. World J Gastroenterol,2011,17(34):3916-3921. doi: 10.3748/wjg.v17.i34.3916

相关文章(20)

[1]	王艾云, 王雨婷, 蔡静, 倪若妍, 罗彩莹, 喻卓, 陈鹏. 肠道菌群及其代谢产物在动脉粥样硬化发生发展中的作用, 昆明医科大学学报.
[2]	代怡琳, 田云粉. 药物在儿童结肠镜检查前肠道准备的应用及研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241024
[3]	李波, 孙杨, 缪应雷. 炎症性肠病的肠道微生态变化及对策, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240401
[4]	胡伟, 李金男, 杨伟, 苏黎, 喻卓, 陈志松. 儿童肌部室间隔缺损的介入治疗研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240307
[5]	聂忠顺, 缪应雷. 生物制剂背景下粪菌移植对炎症性肠病的应用前景, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241023
[6]	牛俊杰, 姬文娟, 于拽拽. 肠道菌群、血清ET、PCT水平与脓毒症病情程度、预后的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240420
[7]	李媛媛, 宋亚贤, 徐玉善, 曾晓甫, 袁惠, 徐兆, 江艳. 肠道菌群代谢物TMAO与非酒精性脂肪性肝病的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240210
[8]	邓绍友, 赵玉兰, 王佩锦, 李蓉, 李进涛, 郑红. 恒古骨伤愈合剂联合广谱抗生素改善db/db小鼠胰岛素抵抗和肠道菌群, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230530
[9]	梁彩红, 孟明耀, 李欣欣, 熊晶晶, 李檬, 刘梅, 侯宗柳, 黄永坤. 肠道菌群代谢物脱氧胆酸对人脐带间充质干细胞hUC-MSCs增殖及细胞周期的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230402
[10]	李抒瑾, 杨艳飞, 苏敏, 凌昱, 饶艳琼, 崔继华. 儿童注意缺陷多动障碍共病情绪问题的单核苷酸多态性研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230420
[11]	李丹, 万绪莲, 李律宇, 云宇, 罗光云, 刘韦兵, 林公府, 李宁, 黎勇坤, 段为钢. 尿酸酶缺失大鼠肠道菌群的变化, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230205
[12]	李露, 田云粉. 肠道菌群与儿童非酒精性脂肪性肝病的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230708
[13]	张莹, 高虹, 张翠香, 陈泽莹, 邹红群, 李丽琼, 杨巨品, 胡月新. 儿童幽门螺杆菌感染情况及其与缺铁性贫血的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220418
[14]	杨顺航, 李炯明, 刘建和, 王光, 李沛. 肠源性高草酸尿症的发病机制与治疗进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220734
[15]	世淑兰, 戴熙廷, 赵广周, 李小娟, 李荣杰, 麻明彪. 16SrRNA基因检测在儿童细菌性脑膜炎早期诊断中的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210522
[16]	黄海林, 李小娟, 尹建雯, 蒋鸿超. 2017年至2020年儿童感染性腹泻沙门菌和志贺菌分布及药敏结果, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210713
[17]	梁睿, 淳于纬训, 沈焘, 孙乐, 李云峰. 肠道菌群和免疫在结直肠肿瘤中作用研究进展, 昆明医科大学学报.
[18]	薛平燕, 江艳, 徐玉善, 袁惠, 李璇, 宋亚贤, 刘华. 肠道菌群结构在非酒精性脂肪性肝病患者中的改变, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20201120
[19]	盛晓翠. 儿童泌尿系感染的病原菌分析, 昆明医科大学学报.
[20]	. 闭合复位克氏针固定治疗儿童肱骨髁上不稳定骨折, 昆明医科大学学报.